trial

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

NCTId NCT05276050
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 50 (estimated)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2026-07-28
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2022-06-01
Primary completion
2026-07-28
Eligibility
ALL · 22 Years · 65 Years

Interventions & indications

Drugs
active F8-coil delivered rTMSactive H-coil delivered rTMS

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Xiaoming Du, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2026-07-28
Status
RECRUITING
relationships
The graph out of here
drug
active F8-coil delivered rTMS
drug
active H-coil delivered rTMS
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Smoking
indication
Nicotine Addiction
indication
Tobacco Use Disorder
indication
investigator
Xiaoming Du, PhD
person